Brady James Aloysius (CIK 1916987) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy XERS (24,193 shares), Sell VRNA (23,176 shares), Buy VRNA (72,000 shares), Sell VRNA (72,000 shares), Buy VRNA (24,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Xeris Biopharma Holdings, Inc. (XERS) | Director | Buy | 24,193 | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Director | Sell | 23,176 | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Director | Buy | 72,000 | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Director | Sell | 72,000 | $0 |
| 2025-08-05 | Verona Pharma plc (VRNA) | Director | Buy | 24,000 | $0 |
| 2025-08-05 | Verona Pharma plc (VRNA) | Director | Sell | 824 | $10,827 |
| 2025-03-28 | Xeris Biopharma Holdings, Inc. (XERS) | Director | Buy | 100,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05